ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in


AUA 2013 - Session Highlights: Revisiting FDG-PET/CT in the primary staging of high risk prostate cancers before local therapies

SAN DIEGO, CA USA (UroToday.com) - Once thought to be of little clinical utility in the prostate cancer space, Dr. Annie-Claude Blouin and colleagues from Quebec evaluated the ability of FDG-PET/CT in staging high risk prostate cancer. To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.